China National Medicines Corporation Ltd., together with its subsidiaries, engages in pharmaceutical equipment circulation in China. The company also manufactures and sells new drugs; sells Chinese patent medicines drug sales and western medicines, and medical equipment; and offers dental drug and equipment, warehousing, logistics and import and export agency services. It also serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China. China National Medicines Corporation Ltd. operates as a subsidiary of Sinopharm Group Co. Ltd.
Research context
China National Medicines Corporation Ltd appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Medical Distribution
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
China National Medicines Corporation Ltd is currently in a long term downtrend where the price is trading 22.4% below its 200 day moving average.
From a valuation standpoint, the stock is 93.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.6.
China National Medicines Corporation Ltd's total revenue sank by 5.6% to $11B since the same quarter in the previous year.
Its net income has dropped by 29.0% to $378M since the same quarter in the previous year.
Finally, its free cash flow grew by 25.9% to $847M since the same quarter in the previous year.
Based on the above factors, China National Medicines Corporation Ltd gets an overall score of 2/5.